-
1
-
-
78649429727
-
Reduced mortality after allogeneic hematopoietic-cell transplantation
-
Gooley TA, Chien JW, Pergam SA, Hingorani S, Sorror ML, Boeckh M et al. Reduced mortality after allogeneic hematopoietic-cell transplantation. N Engl J Med 2010; 363: 2091-2101
-
(2010)
N Engl J Med
, vol.363
, pp. 2091-2101
-
-
Gooley, T.A.1
Chien, J.W.2
Pergam, S.A.3
Hingorani, S.4
Sorror, M.L.5
Boeckh, M.6
-
2
-
-
80355129623
-
Long-Term outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation for advanced hematologic malignancies
-
Sorror ML, Sandmaier BM, Storer BE, Franke GN, Laport GG, Chauncey TR et al. Long-Term outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation for advanced hematologic malignancies. JAMA 2011; 306: 1874-1883
-
(2011)
JAMA
, vol.306
, pp. 1874-1883
-
-
Sorror, M.L.1
Sandmaier, B.M.2
Storer, B.E.3
Franke, G.N.4
Laport, G.G.5
Chauncey, T.R.6
-
3
-
-
70350090181
-
Risk score for outcome after allogeneic hematopoietic stem cell transplantation: A retrospective analysis
-
Gratwohl A, Stern M, Brand R, Apperley J, Baldomero H, de Witte T et al. Risk score for outcome after allogeneic hematopoietic stem cell transplantation: A retrospective analysis. Cancer 2009; 115: 4715-4726
-
(2009)
Cancer
, vol.115
, pp. 4715-4726
-
-
Gratwohl, A.1
Stern, M.2
Brand, R.3
Apperley, J.4
Baldomero, H.5
De Witte, T.6
-
4
-
-
27644494220
-
Conditioning with 8-Gy total body irradiation and fludarabine for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia
-
Stelljes M, Bornhauser M, Kroger M, Beyer J, Sauerland MC, Heinecke A et al. Conditioning with 8-Gy total body irradiation and fludarabine for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia. Blood 2005; 106: 3314-3321
-
(2005)
Blood
, vol.106
, pp. 3314-3321
-
-
Stelljes, M.1
Bornhauser, M.2
Kroger, M.3
Beyer, J.4
Sauerland, M.C.5
Heinecke, A.6
-
5
-
-
79959959049
-
Allogeneic transplantation as post-remission therapy for cytogenetically high-risk acute myeloid leukemia: Landmark analysis from a single prospective multicenter trial
-
Stelljes M, Beelen DW, Braess J, Sauerland MC, Heinecke A, Berning B et al. Allogeneic transplantation as post-remission therapy for cytogenetically high-risk acute myeloid leukemia: Landmark analysis from a single prospective multicenter trial. Haematologica 2011; 96: 972-979
-
(2011)
Haematologica
, vol.96
, pp. 972-979
-
-
Stelljes, M.1
Beelen, D.W.2
Braess, J.3
Sauerland, M.C.4
Heinecke, A.5
Berning, B.6
-
6
-
-
69249221392
-
Compassionate use of sorafenib in FLT3-ITD-positive acute myeloid leukemia: Sustained regression before and after allogeneic stem cell transplantation
-
Metzelder S, Wang Y, Wollmer E, Wanzel M, Teichler S, Chaturvedi A et al. Compassionate use of sorafenib in FLT3-ITD-positive acute myeloid leukemia: Sustained regression before and after allogeneic stem cell transplantation. Blood 2009; 113: 6567-6571
-
(2009)
Blood
, vol.113
, pp. 6567-6571
-
-
Metzelder, S.1
Wang, Y.2
Wollmer, E.3
Wanzel, M.4
Teichler, S.5
Chaturvedi, A.6
-
7
-
-
84857999119
-
Azacitidine for treatment of imminent relapse in mds or aml patients after allogeneic hsct: Results of the relaza trial
-
Platzbecker U, Wermke M, Radke J, Oelschlaegel U, Seltmann F, Kiani A et al. Azacitidine for treatment of imminent relapse in MDS or AML patients after allogeneic HSCT: Results of the RELAZA trial. Leukemia 2012; 26: 381-389
-
(2012)
Leukemia
, vol.26
, pp. 381-389
-
-
Platzbecker, U.1
Wermke, M.2
Radke, J.3
Oelschlaegel, U.4
Seltmann, F.5
Kiani, A.6
-
8
-
-
84856857935
-
Treatment, risk factors, and outcome of adults with relapsed AML after reduced intensity conditioning for allogeneic stem cell transplantation
-
Schmid C, Labopin M, Nagler A, Niederwieser D, Castagna L, Tabrizi R et al. Treatment, risk factors, and outcome of adults with relapsed AML after reduced intensity conditioning for allogeneic stem cell transplantation. Blood 2012; 119: 1599-1606
-
(2012)
Blood
, vol.119
, pp. 1599-1606
-
-
Schmid, C.1
Labopin, M.2
Nagler, A.3
Niederwieser, D.4
Castagna, L.5
Tabrizi, R.6
-
9
-
-
0037370833
-
The usefulness of monitoring WT1 gene transcripts for the prediction and management of relapse following allogeneic stem cell transplantation in acute type leukemia
-
Ogawa H, Tamaki H, Ikegame K, Soma T, Kawakami M, Tsuboi A et al. The usefulness of monitoring WT1 gene transcripts for the prediction and management of relapse following allogeneic stem cell transplantation in acute type leukemia. Blood 2003; 101: 1698-1704
-
(2003)
Blood
, vol.101
, pp. 1698-1704
-
-
Ogawa, H.1
Tamaki, H.2
Ikegame, K.3
Soma, T.4
Kawakami, M.5
Tsuboi, A.6
-
10
-
-
37449023112
-
Monitoring of minimal residual disease in acute myeloid leukemia
-
Kern W, Haferlach C, Haferlach T, Schnittger S. Monitoring of minimal residual disease in acute myeloid leukemia. Cancer 2008; 112: 4-16
-
(2008)
Cancer
, vol.112
, pp. 4-16
-
-
Kern, W.1
Haferlach, C.2
Haferlach, T.3
Schnittger, S.4
-
11
-
-
80054717409
-
Minimal residual disease markers before and after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia
-
Dominietto A. Minimal residual disease markers before and after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia. Curr Opin Hematol 2011; 18: 381-387
-
(2011)
Curr Opin Hematol
, vol.18
, pp. 381-387
-
-
Dominietto, A.1
-
12
-
-
84855838173
-
Prognostic and therapeutic implications of minimal residual disease detection in acute myeloid leukemia
-
Buccisano F, Maurillo L, Del Principe MI, Del Poeta G, Sconocchia G, Lo-Coco F et al. Prognostic and therapeutic implications of minimal residual disease detection in acute myeloid leukemia. Blood 2012; 119: 332-341
-
(2012)
Blood
, vol.119
, pp. 332-341
-
-
Buccisano, F.1
Maurillo, L.2
Del Principe, M.I.3
Del Poeta, G.4
Sconocchia, G.5
Lo-Coco, F.6
-
13
-
-
19944386205
-
Prediction of relapse of acute myeloid leukemia in allogeneic transplant recipients by marrow CD34+ donor cell chimerism analysis
-
Scheffold C, Kroeger M, Zuehlsdorf M, Tchinda J, Silling G, Bisping G et al. Prediction of relapse of acute myeloid leukemia in allogeneic transplant recipients by marrow CD34+ donor cell chimerism analysis. Leukemia 2004; 18: 2048-2050
-
(2004)
Leukemia
, vol.18
, pp. 2048-2050
-
-
Scheffold, C.1
Kroeger, M.2
Zuehlsdorf, M.3
Tchinda, J.4
Silling, G.5
Bisping, G.6
-
14
-
-
18644365146
-
Evaluation of immunomodulatory treatment based on conventional and lineage-specific chimerism analysis in patients with myeloid malignancies after myeloablative allogeneic hematopoietic cell transplantation
-
Zeiser R, Spyridonidis A, Wasch R, Ihorst G, Grullich C, Bertz H et al. Evaluation of immunomodulatory treatment based on conventional and lineage-specific chimerism analysis in patients with myeloid malignancies after myeloablative allogeneic hematopoietic cell transplantation. Leukemia 2005; 19: 814-821
-
(2005)
Leukemia
, vol.19
, pp. 814-821
-
-
Zeiser, R.1
Spyridonidis, A.2
Wasch, R.3
Ihorst, G.4
Grullich, C.5
Bertz, H.6
-
15
-
-
70449432763
-
Monitoring of donor chimerism in sorted CD34+ peripheral blood cells allows the sensitive detection of imminent relapse after allogeneic stem cell transplantation
-
Bornhauser M, Oelschlaegel U, Platzbecker U, Bug G, Lutterbeck K, Kiehl MG et al. Monitoring of donor chimerism in sorted CD34+ peripheral blood cells allows the sensitive detection of imminent relapse after allogeneic stem cell transplantation. Haematologica 2009; 94: 1613-1617
-
(2009)
Haematologica
, vol.94
, pp. 1613-1617
-
-
Bornhauser, M.1
Oelschlaegel, U.2
Platzbecker, U.3
Bug, G.4
Lutterbeck, K.5
Kiehl, M.G.6
-
16
-
-
0035195063
-
Leukemia lineage-specific chimerism analysis is a sensitive predictor of relapse in patients with acute myeloid leukemia and myelodysplastic syndrome after allogeneic stem cell transplantation
-
Mattsson J, Uzunel M, Tammik L, Aschan J, Ringden O. Leukemia lineage-specific chimerism analysis is a sensitive predictor of relapse in patients with acute myeloid leukemia and myelodysplastic syndrome after allogeneic stem cell transplantation. Leukemia 2001; 15: 1976-1985
-
(2001)
Leukemia
, vol.15
, pp. 1976-1985
-
-
Mattsson, J.1
Uzunel, M.2
Tammik, L.3
Aschan, J.4
Ringden, O.5
-
17
-
-
0033008061
-
Rapid quantification of mixed chimerism using multiplex amplification of short tandem repeat markers and fluorescence detection
-
Thiede C, Florek M, Bornhauser M, Ritter M, Mohr B, Brendel C et al. Rapid quantification of mixed chimerism using multiplex amplification of short tandem repeat markers and fluorescence detection. Bone Marrow Transplant 1999; 23: 1055-1060
-
(1999)
Bone Marrow Transplant
, vol.23
, pp. 1055-1060
-
-
Thiede, C.1
Florek, M.2
Bornhauser, M.3
Ritter, M.4
Mohr, B.5
Brendel, C.6
-
18
-
-
0035383779
-
High frequency of immunophenotype changes in acute myeloid leukemia at relapse: Implications for residual disease detection (cancer and leukemia group b study 8361
-
Baer MR, Stewart CC, Dodge RK, Leget G, Sule N, Mrozek K et al. High frequency of immunophenotype changes in acute myeloid leukemia at relapse: Implications for residual disease detection (Cancer and Leukemia Group B Study 8361). Blood 2001; 97: 3574-3580
-
(2001)
Blood
, vol.97
, pp. 3574-3580
-
-
Baer, M.R.1
Stewart, C.C.2
Dodge, R.K.3
Leget, G.4
Sule, N.5
Mrozek, K.6
-
19
-
-
0026734476
-
Surface marker expression in acute myeloid leukaemia at first relapse
-
Thomas X, Campos L, Archimbaud E, Shi ZH, Treille-Ritouet D, Anglaret B et al. Surface marker expression in acute myeloid leukaemia at first relapse. Br J Haematol 1992; 81: 40-44
-
(1992)
Br J Haematol
, vol.81
, pp. 40-44
-
-
Thomas, X.1
Campos, L.2
Archimbaud, E.3
Shi, Z.H.4
Treille-Ritouet, D.5
Anglaret, B.6
-
20
-
-
50049103382
-
Minimal residual disease diagnostics in myeloid malignancies in the post transplant period
-
Bacher U, Zander AR, Haferlach T, Schnittger S, Fehse B, Kroger N. Minimal residual disease diagnostics in myeloid malignancies in the post transplant period. Bone Marrow Transplant 2008; 42: 145-157
-
(2008)
Bone Marrow Transplant
, vol.42
, pp. 145-157
-
-
Bacher, U.1
Zander, A.R.2
Haferlach, T.3
Schnittger, S.4
Fehse, B.5
Kroger, N.6
-
21
-
-
0026635197
-
Cytogenetics for detection of minimal residual disease in acute myeloblastic leukemia
-
Freireich EJ, Cork A, Stass SA, McCredie KB, Keating MJ, Estey EH et al. Cytogenetics for detection of minimal residual disease in acute myeloblastic leukemia. Leukemia 1992; 6: 500-506
-
(1992)
Leukemia
, vol.6
, pp. 500-506
-
-
Freireich, E.J.1
Cork, A.2
Stass, S.A.3
McCredie, K.B.4
Keating, M.J.5
Estey, E.H.6
-
22
-
-
77449159028
-
Diagnosis and management of acute myeloid leukemia in adults: Recommendations from an international expert panel, on behalf of the European LeukemiaNet
-
Dohner H, Estey EH, Amadori S, Appelbaum FR, Buchner T, Burnett AK et al. Diagnosis and management of acute myeloid leukemia in adults: Recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood 2010; 115: 453-474
-
(2010)
Blood
, vol.115
, pp. 453-474
-
-
Dohner, H.1
Estey, E.H.2
Amadori, S.3
Appelbaum, F.R.4
Buchner, T.5
Burnett, A.K.6
-
23
-
-
42949142189
-
Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia
-
Schlenk RF, Dohner K, Krauter J, Frohling S, Corbacioglu A, Bullinger L et al. Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia. N Engl J Med 2008; 358: 1909-1918
-
(2008)
N Engl J Med
, vol.358
, pp. 1909-1918
-
-
Schlenk, R.F.1
Dohner, K.2
Krauter, J.3
Frohling, S.4
Corbacioglu, A.5
Bullinger, L.6
-
24
-
-
79960127726
-
Monitoring of minimal residual disease in npm1-mutated acute myeloid leukemia: A study from the german-Austrian acute myeloid leukemia study group
-
Kronke J, Schlenk RF, Jensen KO, Tschurtz F, Corbacioglu A, Gaidzik VI et al. Monitoring of minimal residual disease in NPM1-mutated acute myeloid leukemia: A study from the German-Austrian acute myeloid leukemia study group. J Clin Oncol 2011; 29: 2709-2716
-
(2011)
J Clin Oncol
, vol.29
, pp. 2709-2716
-
-
Kronke, J.1
Schlenk, R.F.2
Jensen, K.O.3
Tschurtz, F.4
Corbacioglu, A.5
Gaidzik, V.I.6
-
25
-
-
79952439621
-
Monitoring of wt1 expression in pb and cd34(+) donor chimerism of bm predicts early relapse in aml and mds patients after hematopoietic cell transplantation with reduced-intensity conditioning
-
Lange T, Hubmann M, Burkhardt R, Franke GN, Cross M, Scholz M et al. Monitoring of WT1 expression in PB and CD34(+) donor chimerism of BM predicts early relapse in AML and MDS patients after hematopoietic cell transplantation with reduced-intensity conditioning. Leukemia 2011; 25: 498-505
-
(2011)
Leukemia
, vol.25
, pp. 498-505
-
-
Lange, T.1
Hubmann, M.2
Burkhardt, R.3
Franke, G.N.4
Cross, M.5
Scholz, M.6
-
26
-
-
47649122245
-
Minimal residual disease detection in acute myeloid leukemia by mutant nucleophosmin (NPM1): Comparison with WT1 gene expression
-
Barragan E, Pajuelo JC, Ballester S, Fuster O, Cervera J, Moscardo F et al. Minimal residual disease detection in acute myeloid leukemia by mutant nucleophosmin (NPM1): Comparison with WT1 gene expression. Clin Chim Acta 2008; 395: 120-123
-
(2008)
Clin Chim Acta
, vol.395
, pp. 120-123
-
-
Barragan, E.1
Pajuelo, J.C.2
Ballester, S.3
Fuster, O.4
Cervera, J.5
Moscardo, F.6
-
27
-
-
51349157656
-
Donor lymphocyte infusions for acute myeloid leukaemia best practice & research
-
Soiffer RJ. Donor lymphocyte infusions for acute myeloid leukaemia. Best practice & research. Clin haematoly 2008; 21: 455-466
-
(2008)
Clin haematoly
, vol.21
, pp. 455-466
-
-
Soiffer, R.J.1
-
28
-
-
81555228422
-
Preemptive immunotherapy in childhood acute myeloid leukemia for patients showing evidence of mixed chimerism after allogeneic stem cell transplantation
-
Rettinger E, Willasch AM, Kreyenberg H, Borkhardt A, Holter W, Kremens B et al. Preemptive immunotherapy in childhood acute myeloid leukemia for patients showing evidence of mixed chimerism after allogeneic stem cell transplantation. Blood 2011; 118: 5681-5688
-
(2011)
Blood
, vol.118
, pp. 5681-5688
-
-
Rettinger, E.1
Willasch, A.M.2
Kreyenberg, H.3
Borkhardt, A.4
Holter, W.5
Kremens, B.6
-
29
-
-
78149413548
-
Leukemia lineage-specific chimerism analysis and molecular monitoring improve outcome of donor lymphocyte infusions
-
Sairafi D, Remberger M, Uhlin M, Ljungman P, Ringden O, Mattsson J. Leukemia lineage-specific chimerism analysis and molecular monitoring improve outcome of donor lymphocyte infusions. Biol Blood Marrow Transplant 2010; 16: 1728-1737
-
(2010)
Biol Blood Marrow Transplant
, vol.16
, pp. 1728-1737
-
-
Sairafi, D.1
Remberger, M.2
Uhlin, M.3
Ljungman, P.4
Ringden, O.5
Mattsson, J.6
|